ArticleCraniomaxillofacial trauma & reconstruction2026
Individual Factors Associated with Health-Related Quality of Life in Facial Cutaneous Squamous Cell Carcinoma-A Pilot Study.
Article in Craniomaxillofacial trauma & reconstruction, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeFacial expressions and aesthetics are vital for communication, self-expression, and social interaction. Therefore, this study aimed to evaluate the impact of localization and size of facial cutaneous squamous cell carcinoma (cSCC) on changes in perceived pre- and postoperative health-related quality of life (HR-QoL).
methodsThis retrospective study included patients who had undergone surgery for facial cSCC. Size, localization and stage were assessed. Pre- and postoperative HR-QoL were evaluated using the Skindex-29. Statistical analyses, including descriptive statistics, the X2 Test, Wilcoxon Test, and repeated-measures ANOVA, were performed to analyze demographic data, tumor characteristics, and changes in HR-QoL.
resultsForty patients (mean age of 78.5 years) were included. Postoperatively, significant improvements were observed in the overall, emotional, and symptomatic HR-QoL. Tumor dimensions had an impact on presurgical emotional distress. For tumor sizes from 6 to 15 mm, significant release in symptom burden and improvement in general HR-QoL were observed. While women experienced notable improvement only in emotional distress, men also exhibited improvement in symptoms, and overall HR-QoL. All age groups showed improvements in emotional distress, symptoms and overall HR-QoL. No significant differences were found in terms of age or localization.
conclusionsThis study suggests that sex, tumor localization, and tumor size may interact in influencing postoperative HR-QoL outcomes in patients with cSCC. While surgical treatment by experienced specialists was associated with an overall improvement in HR-QoL following successful tumor eradication, these findings should be interpreted with caution given the limited sample size. The results indicate that surgery remains an important first-line treatment option, particularly for medium-sized tumors. In this cohort, TNM classification was not associated with postoperative HR-QoL changes; however, interpretation is limited by the predominance of early-stage tumors. Further studies with larger patient populations are required to confirm these observations and to better elucidate the relationship between clinical staging and HR-QoL outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.